A carregar...
Aromatase inhibitor use is a risk factor of carotid plaque presence in endocrine-responsive breast cancer patients
BACKGROUND/AIMS: The aromatase inhibitors (AIs) are well known anti-hormonal therapy in endocrine-responsive breast cancer patients. It can lead to dyslipidemia and be the risk factor of cardiovascular disease due to low estrogen level. However, some recent studies comparing AIs with placebo have sh...
Na minha lista:
| Publicado no: | Korean J Intern Med |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Korean Association of Internal Medicine
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6506747/ https://ncbi.nlm.nih.gov/pubmed/28838227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2016.205 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|